Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
FAQ
- What is Harmony Biosciences Holdings, Inc.'s EBIT?
- Harmony Biosciences Holdings, Inc. (HRMY) reported EBIT of $37.29M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s EBIT changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s EBIT decreased by 33.7% year-over-year, from $56.25M to $37.29M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s EBIT has grown at a 24.2% compound annual growth rate (CAGR), from $87.53M to $208.47M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Harmony Biosciences Holdings, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude